Identification and characterization of the Bel 3 protein of human foamy virus. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Identification and characterization of the Bel 3 protein of human foamy virus.

AIDS Res Hum Retroviruses. 1994 May;10(5):595-600. Unique Identifier : AIDSLINE MED/95000932
Weissenberger J; Flugel RM; Abteilung Retrovirale Genexpression, Forschungsschwerpunkt; Angewandte Tumorvirologie, Deutsches Krebsforschungszentrum,; Heidelberg, Germany.


Abstract: The human foamy virus (HFV) is a complex retrovirus that contains several regulatory and auxiliary bel genes besides the gag, pol, and env genes. In contrast to the gene products of bel 1 and bel 2/bet that were identified previously, the Bel 3 protein has not been described to date. Here we report the identification of Bel 3 in HFV-infected cells by immunoprecipitation, indirect immunofluorescence, and expression cloning under the control of a strong heterologous promoter. Bel 3 was immunoprecipitated with an antiserum directed against a bacterially expressed and purified form of recombinant Bel 3 antigen. Bel 3 was found to be expressed in low amounts in the cytoplasm of HFV-infected cells and to migrate with an apparent molecular mass of 19.4 kDa on electrophoresis in SDS-polyacrylamide gels, consistent with the calculated value of 18.2 kDa. Radioimmunoprecipitation of HFV-infected cell lysates with the hyperimmune serum against Bel 3 revealed at least two additional immunoreactive bands of 15.5 and 10.6 kDa. The results indicate that Bel 3 was labile, because it was partially degraded even at early time points after infection. On transfection and expression in transfected COS cells, recombinant Bel 3 was immunoprecipitated and migrated in three polypeptide bands of 18.7, 14.8, and 9.3 kDa under denaturing conditions. In the absence of reducing agents, the bacterially expressed and purified recombinant Bel 3 protein of 16.1 kDa can form homodimers of 30 kDa.
Keywords: Animal Base Sequence Cell Line Cloning, Molecular DNA Primers/GENETICS Escherichia coli/GENETICS Gene Expression Genes, Viral Human Immunohistochemistry Molecular Sequence Data Molecular Weight Retroviridae Proteins/*GENETICS/IMMUNOLOGY/ISOLATION & PURIF Spumavirus/*GENETICS/IMMUNOLOGY Support, Non-U.S. Gov't Transfection JOURNAL ARTICLEKWDanimalbasesequencecelllinecloning,moleculardnaprimers/geneticsescherichiacoli/geneticsgeneexpressiongenes,viralhumanimmunohistochemistrymolecularsequencedatamolecularweightretroviridaeproteins/KWDgenetics/immunology/isolation&purifspumavirus/KWDgenetics/immunologysupport,non-uKWDsKWDgov'ttransfectionjournalarticle
950130
M9510839

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .